| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.0075 | 0.9 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |